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Abstract 
Mouse protein tyrosine phosphatase PTPBR7 is a receptor-like, transmembrane protein that 
is localized on the surface of neuronal cells. Its protein phosphatase activity is reduced upon 
multimerization, and PTPBR7-deficient mice display motor coordination defects. Extracellular 
molecules that may influence PTPBR7 activity, however, remain to be determined. We here 
show that the PTPBR7 extracellular domain binds to highly myelinated regions in mouse brain, 
in particular the white matter tracks in cerebellum. PTPBR7 deficiency does not alter this 
binding pattern, as witnessed by RAP in situ staining of Ptprr-/- mouse brain sections. Additional 
in situ and in vitro experiments also suggest that sugar moieties of heparan sulphate and 
chondroitin sulphate glycosaminoglycans are not critical for PTPBR7 binding. Candidate 
binding proteins were affinity-purified exploiting the PTPBR7 extracellular domain and iden-
tified by mass spectrometric means. Results support the suggested link between PTPRR 
isoforms and cerebellar calcium ion homeostasis, and suggest an additional role in the process 
of cell-cell adhesion. 
Key words: cerebellum; RAP in situ; extracellular domain; ligand protein; PTPRR; protein tyrosine 
phosphatase; mass spectrometry. 
Introduction 
Molecular and cellular mechanisms that underlie 
the development and function of the vertebrate 
nervous system include signalling events by cell ad-
hesion molecules (CAMs) and Receptor Tyrosine Ki-
nases [1, 2]. Receptor Protein Tyrosine Phosphatases 
(RPTPs) regulate phosphotyrosine signalling by 
counteracting the tyrosine kinases [3]. RPTPs show 
strong developmental expression in the central (CNS) 
and peripheral nervous system, coinciding with sig-
nificant events such as axogenesis, target contact, 
synaptogenesis and plasticity [4, 5]. The structural 
resemblance of many RPTPs to neural CAMs (for 
example Immunoglobulin-like domains and Fibron-
ectin type III domains) has made them candidate re-
ceptors for contact-mediated cues encountered by 
growth cones. Indeed in vivo roles for RPTPs in neural 
development and function have been shown [3, 4].  
Although numerous downstream effectors of 
RPTP signalling have been identified, the ligands 
have been discovered for only a small number of 
RPTPs [6]. The CAM-like subfamily members RPTPμ, 
RPTPκ, RPTPλ and RPTPδ all display homophilic 
interactions that are important in cell adhesion pro-
cesses [6, 7]. Although RPTPσ and PTP-LAR have an 
extracellular segment that is similar to these homo-
philic RPTPs, they rather bind to multiple other ex-
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tracellular proteins. RPTPδ, RPTPσ and PTP-LAR all 
three bind netrin-G ligand-3 (NGL-3) [8]. RPTPσ 
binds nucleolin, alpha latroxin, contactin, the heparan 
sulphate (HS) proteoglycans agrin and collagen ΧVІІІ, 
and chondroitin-sulphate (CS) produced by astroglia 
[9-13]. A splice form of human PTP-LAR binds the 
laminin-nidogen complex, a major component of the 
extracellular matrix that modulates neurite out-
growth, proliferation and differentiation [14]. The 
Drosophila homolog DLAR influences the develop-
ment of synapses through the binding of two HS 
proteoglycans, syndecan and dallylike, that have 
positive and negative effects, respectively, on its PTP 
activity [7]. The homologous RPTPγ and RPTPζ each 
bind to distinct contactin family members [15]. In ad-
dition, RPTPζ can interact with tenascin and plei-
othropin but, intriguingly, only for the latter an effect 
on activity was reported [16]. Pleiothropin binding 
resulted in RPTPζ dimerisation and inactivation, as 
had been found for several other RPTPs upon the ar-
tificial induction of dimers [6].  
PTPBR7, a receptor-type isoform that is encoded 
by the mouse Ptprr gene, appears on the cell surface as 
a homomultimeric protein that displays a much re-
duced phosphatase activity when compared to the 
monomeric Ptprr-encoded, cytosolic variants [17]. 
Prenatally, PTPBR7 is expressed in spinal ganglia and 
in Purkinje precursor cells within the developing 
cerebellum. After birth, PTPBR7 transcripts gradually 
decrease in the maturing Purkinje cells (PCs) and re-
main expressed throughout all other brain regions 
[18], suggestive of a neurodevelopmental role. Unex-
pectedly, Ptprr knockout mice did not display overt 
brain malformations but rather performed quite 
poorly in various locomotive tests [19], reminiscent of 
findings in ataxic animal models with deficits in cer-
ebellar calcium ion homeostasis [20].  
Here we report on the ligand binding potential 
of the PTPBR7 extracellular segment, which does not 
contain any known CAM-like or protein interaction 
motifs. Using Receptor Alkaline Phosphatase in situ 
(RAP in situ) methodology [21, 22] we demonstrate 
PTPBR7 ectodomain binding to myelinated regions in 
mouse brain. Affinity purification and identification 
of associating proteins supports a role for PTPBR7 in 
cell-cell adhesion and Ca2+-regulated processes in the 
mouse brain. 
Materials and methods 
RT-PCR and cloning 
C57BL/6 mouse brain RNA preparations were 
subjected to RT-PCR to obtain cDNA fragments en-
coding the extracellular domain of PTPBR7, including 
its signal peptide. Approximately 5 µg of total RNA 
was reverse-transcribed by random hexamers prim-
ing and the SuperScript first-strand synthesis system 
(Invitrogen, Carlsbad, CA). Resulting cDNA was 
subsequently used in a standard PCR reaction with 
primers bearing restriction sites for EcoRI or KpnI to 
facilitate cloning. Primer sequences were: BR7ecto 
forward, 5’- ATGAATTCGCGGCCGCCACCATGAG 
GAGAGCGGTCGGC - 3’; BR7ecto226 reverse, 
5’-AGGGTACCTCCTTCTTTGCTCCAGATC-3’; 
BR7ecto225 reverse, 5’- AGGGTACCTTCTTTGCT 
CCAGATCTTG-3’; BR7ecto224 reverse, 5’- 
AGGGTACCTTTGCTCCAGATCTTGTC-3’; 
BR7ecto223 reverse, 5’- AGGGTACCGCTCCAGA 
TCTTGTCTGC-3’; BE7ecto222 reverse, 5’- 
AGGGTACCCCAGATCTTGTCTGCTTC-3’; 
BR7ecto221 reverse, 5’- AGGGTACCGATCTTGT 
CTGCTTCGTG-3’; BR7ecto220 reverse, 5’- 
TGGGTACCCTTGTCTGCTTCGTGCTG-3’.  
The mammalian expression plasmid 
pBG-flexilinker was generated from pBG [11] by in-
serting a linker encoding GGGGSGGGGSP upstream 
of the PLAP open reading frame (Supplementary 
Material: Fig. S1). pBG-flexilinker was linearized us-
ing HindIII and ClaI in order to introduce an adapter 
sequence containing EcoRI and KpnI sites (a hetero-
duplex of oligonucleotides 5’- AGCTGAATTCT 
TAAGGTACCT-3’ and 5’- CGAGGTACCTTAAG 
AATTC-3’). The mammalian expression plasmid 
pHLsec [23] and a version containing the extracellular 
domain of RPTPµ (eRPTPµ) [24] were kindly pro-
vided by Dr. Aricescu. The unique EcoRI and KpnI 
restriction sites allowed insertion of the BR7ecto226 
PCR product into empty pHLsec to generate plasmid 
pHLsec-BR7ecto226-His. 
Antibodies, Glycosaminoglycans (GAGs) and 
GAGs hydrolytic enzymes  
Rabbit polyclonal antiserum α-BR7 directed to-
wards the extracellular domain of PTPBR7, an-
ti-VSV-G tag monoclonal antibody P5D4, and single 
chain variable fragment antibodies to HS (HS4C3), 
CS-A and -C (IO3H10), and CS-E (GD3G7) are de-
scribed elsewhere [25-29]. Monoclonal antibody 11-5B 
to CNPase, goat anti-mouse Alexa-Fluor488 antibody, 
and rabbit anti-mouse alkaline phospha-
tase-conjugated antibody were from Dakopatts 
(Glostrup, Denmark), Millipore (Billerica, MA) and 
Invitrogen, respectively. Heparanase III (Flavobacte-
rium heparinum) was from Ibex Technologies Inc. 
(Quebec). Bovine kidney HS, shark cartilage CS-A and 
CS-C and chondroitinase ABC (Proteus vulgaris) were 
from Sigma-Aldrich (St. Louis, MO). Shark cartilage 
CS-D and squid cartilage CS-E were from Seikagaku 
(Tokyo, Japan). 
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Cell culture and transient transfection  
HEK293T cells (ATCC nr. CRL-11268) were cul-
tured in humidified chambers at 37°C and 5% CO2 
using Dulbecco’s Modified Eagle’s Medium (DMEM) 
reconstituted with pyruvate and glutamine and sup-
plemented with 10% foetal calf serum. When cells in 
T75 cm2 flasks reached 60-70% confluency, they were 
transfected using the DEAE-dextran method [26] and 
cultured in DMEM, 10% foetal calf serum. After 48 
hours conditioned culture media were collected, ster-
ile-filtered and buffered with 20 mM Hepes (pH 7.4) 
[30]. Alkaline phosphatase (AP) activity in the me-
dium was determined using pNPP (Eastman Kodak, 
Rochester, NY) [30]. 
Brain tissue sections and lysates 
Wild type and Ptprr knockout mice of 9 - 12 
months of age were anesthetized and perfused with 
PBS. Whole brains were extracted, snap frozen in liq-
uid nitrogen-cold isopentane, and stored at -80°C or 
used for sagittal and coronal cryosectioning [30]. The 
10 μm cryosections were dried under air flow at RT.  
To prepare brain lysates, frozen brains were 
thawed and homogenized at 4°C in buffer containing 
50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton 
X-100, 1mM PMSF, 10 mM NaF, 1 mM Na3VO4 and 
protease inhibitor cocktail (Roche Diagnostics GmbH, 
Mannheim, Germany). 
Receptor alkaline phosphatase (RAP) in situ 
staining 
For RAP in situ applications [30] cryosections 
were thawed at RT and processed using published 
methods [31]. The conditioned media containing the 
various AP-fused PTPBR7 extracellular domains were 
used as probe and PLAP-containing medium served 
as background control. Each assay employed 200 
µl/section of conditioned culture medium containing 
the same AP activity. For some applications condi-
tioned media were first concentrated using Vivaspin 
15 membranes (Sartorius Stedim Biotech GmbH, 
Germany). The staining was at RT overnight using 
NBT-BCIP (Sigma-Aldrich, St. Louis, MO) as sub-
strate [30].  
After the RAP in situ procedure sections were 
briefly washed in milliQ, embedded in a wa-
ter-soluble embedding and examined on a Leica DM 
LB microscope with HC PL Fluotar objective (Leica 
Microsystem GmbH, Germany). In each experiment 
minimally three sections per condition were analyzed. 
Per section three digital images of cerebellar white 
matter were taken and for each the mean gray value 
in three representative areas was determined using 
ImageJ [32]. Statistical analyses involved Student’s 
t-test.  
For some experiments tissue sections received a 
pre-treatment with chondroitinase, involving an 
overnight incubation at RT in 1 IU/ml chondroitinase 
ABC digestion mix (Sigma-Aldrich) or in chon-
droitinase buffer alone (50 mM Tris-HCl pH 8.0, 60 
mM sodium acetate, 0.02% BSA) as control. Activity of 
the enzyme under these conditions was assessed in-
dependently in a GAG ELISA (see below).  
Immunohistochemistry and immunoblotting 
Cryosections were briefly rinsed at RT in TBS 
and fixed for 10 minutes in acetone at -20°C. After 2 
washes, endogenous mouse immunoglobulins were 
blocked using the VECTOR M.O.M Immunodetection 
Kit (VECTOR Laboratories, Inc. Burlingame, CA). 
After blocking, sections were washed twice in TBS 
and pre-incubated 10 minutes in primary antibody 
M.O.M. Diluent in TBS supplemented with 2% Goat 
Serum. Sections were then incubated for 2 hours at RT 
with anti CNPase (1:100 dilution), washed twice in 
TBS and incubated for 1 hour at RT with 
goat-anti-mouse-conjugated Alexa-Fluor488 (1:500 
dilution). Finally, sections were washed twice in TBS, 
embedded in Mowiol (Sigma-Aldrich) and analyzed 
by fluorescence microscopy (Leica DMRA). 
For immunoblotting, conditioned medium was 
mixed with sample buffer, subjected to SDS-PAGE 
and blotted onto PVDF membranes by elec-
tro-transfer. Membranes were incubated with rabbit 
polyclonal antiserum α-BR7 (1:3000 dilution) in TBS 
containing 0.5% Tween 20 and 3% BSA, followed by 
Alexa-Fluor680- conjugated goat-anti-rabbit antibody 
(1:10000 dilution) in the same buffer. Immunoreactive 
bands were visualized on an Odyssey infrared imag-
ing system (LI-COR Biosciences, Lincoln, NE). 
Affinity purification using His-tagged PTPBR7 
ectodomain 
His-Select Nickel affinity gel (Sigma-Aldrich) 
was washed in washing buffer (50 mM Tris-HCl, pH 
8.0; 300 mM NaCl; 1mM PMSF) and incubated on an 
orbital shaker for 2 hours at 4˚C with conditioned 
medium from cells expressing BR7ecto226-His, the 
His-tagged RPTPµ extracellular domain [24], or with 
medium from untransfected control cells. Beads were 
then collected and washed 3 times with washing 
buffer containing 10 mM imidazole. Subsequently, 
beads were incubated with brain lysate overnight at 
4°C on an orbital shaker. Beads were again collected 
and washed in washing buffer with 1% Triton X-100 
and 150 mM NaCl. Bound proteins were eluted in the 
same buffer containing 250 mM imidazole. Eluates 
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were mixed with sample buffer, boiled and subjected 
to SDS-PAGE. Following staining with Coomassie 
Brilliant Blue, relevant parts were sliced out and used 
for LC-MS analysis (see below). 
GAG ELISA 
GAG binding to the extracellular domain of 
PTPBR7 was tested using a modified ELISA set-up 
[25]. 100 µl of HS, CS-A, CS-C, CS-D or CS-E (all 10 
μg/ml) were coated in 96-well microplates at RT 
overnight. Excess GAGs was removed by washing 6 
times in ELISA buffer (0.2 M NaCl in PBST). Wells 
were blocked at RT for 1 hour using 3% cold water 
fish skin gelatin in ELISA buffer. After 6 washes dif-
ferent dilutions of conditioned medium containing 
BR7ecto226 AP-tagged protein were added to the 
wells and incubation was for 1.5 hours at RT in the 
dark. Following another 6 washes, 100 μl of phos-
phatase reaction mix (1 mg/ml pNPP in SEAP buffer 
[30]) per well were added. After incubating for 2 
hours at RT absorbance at 405 nm was recorded using 
a Wallac Victor 3 reader (Perkin Elmer, Waltham, 
MA).  
Some of the CS-A, CS-C and CS-E -coated mi-
croplate wells were used to check chondroitinase ABC 
enzyme activity. Following an overnight digestion 
with 1 IU/ml chondroitinase ABC and several washes 
with PBST, these wells were incubated with 100 μl of 
VSV-tagged CS-specific single-chain variable frag-
ment antibodies (1:10 dilution). Subsequent incuba-
tions were done using anti-VSV monoclonal antibody 
P5D4 (1:10 dilution) followed by AP-conjugated rab-
bit anti-mouse antibody (1:1000). After 6 washes, 100 
µl of 1 mg/ml pNPP in SEAP buffer [30] was added 
per well and absorbance at 405 nm was recorded.  
In-Gel digestion 
Coomassie Brilliant Blue-stained gel bands were 
minced and destained by 3 consecutive washes in 750 
µl buffer containing 200 mM ammonium bicarbonate 
in 50% (v/v) acetonitrile for 30 min at 30°C. After 
drying the gel pieces in a Speedvac (Thermo Savant, 
Holbrook, USA), 200 µl trypsin solution (0.002 µg/µl 
in a 50 mM ammonium bicarbonate buffer solution, 
pH 8.0) was added and allowed to be absorbed by the 
gel for 45 min on ice. Gel bands were completely im-
mersed by adding additional 800 µl buffer solution 
and incubated at 37°C overnight. The supernatant 
was recovered, and the resulting peptides were ex-
tracted twice with 500 µl of 60% (v/v) acetonitrile, 
0.1% (v/v) formic acid. The pooled peptide extracts 
were dried in a SpeedVac and resuspended in 15 µl 
2% (v/v) acetonitrile, 0.1% (v/v) formic acid for 
analysis by liquid chromatography tandem mass 
spectrometry (LC-MS/MS). 
LC-ESI-FT-MS/MS 
A volume of 5 µl of each fraction was analyzed 
independently using a fully automated LC-MS/MS 
setup. Peptides were first separated on an Agilent 
1200 chromatographic system (Agilent, Santa Clara, 
CA, USA) and on-line measured on a LTQ-FT Ultra 
mass spectrometer (Thermo Fisher Scientific, Wal-
tham, MA, USA). The samples were first loaded and 
desalted on a (5 mm x 0.3 mm) Zorbax 300SB-C18 
trapping column at a 4 µl/min flow rate using a 2% 
(v/v) acetonitrile, 0.1% formic acid buffer, and then 
separated on a (150 mm x 75 µm) Zorbax 300SB-C18 
analytical column (Agilent) by a 50 min linear gradi-
ent ranging from 2% (v/v) to 80% (v/v) acetonitrile, 
0.1% formic acid at a 0.3 µl/min flow rate. The 
LC-effluent was directly coupled to a Triversa Na-
noMate ESI source (Advion, Ithaca, NY, USA), work-
ing in nano-LC mode and equipped with a D-chip 
whereon a 1.55 kV voltage was supplied. During the 
LC-separation the FT-ICR mass analyzer acquired MS 
scans at 100,000 resolution, the 3 most intense pre-
cursor peptides for each MS scan were automatically 
selected and fragmented by the LTQ ion trap mass 
analyzer. 
Mass spectrometry data handling 
Raw LC-ESI-FT-MS/MS data were analyzed 
using Mascot Daemon v2.2.2 (Matrix Science. Londen, 
UK). The processed spectra were searched against the 
SwissProt Mus musculus database (Swiss-Prot release 
57.15). Carbamidomethyl (C) and oxidation (HMW) 
were selected as variable modifications, and two 
missed cleavage were allowed with trypsin as the 
cleaving agent. Decoy database searches were done 
with a tolerance of 10 ppm for the precursor ion and 
0.5 Da in the MS/MS mode. Keratins were excluded 
from the final protein list. Only protein identifications 
with a calculated protein probability higher than 0.99 
and with MS/MS ionscore ≥ 30 were retained. 
Results 
PTPBR7 ectodomain probes for RAP in situ 
To investigate whether the Ptprr-encoded re-
ceptor-like isoform PTPBR7 displays ligand binding 
potential, we generated a panel of fusion proteins to 
be used in the RAP in situ technique [30]. Briefly, 
seven cDNA fragments encoding the extracellular 
domain of PTPBR7 were fused in-frame with the 
PLAP coding sequence via an intervening, flexible 
peptide linker (Supplementary Material: Fig. S1). All 
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started at PTPBR7 amino acid (aa) codon 1 and ended 
at codon 220, 221, 222, 223, 224, 225 or 226, respec-
tively (Fig. 1A). This variety of probes serves selection 
on the basis of optimal fusion protein yield and con-
formational flexibility required for the binding assay. 
After transfection of HEK293T cells, expression 
levels and sizes of the ectodomain probes were mon-
itored on western blots using antiserum α-BR7 [26]. 
All probes except BR7ecto225 were properly secreted 
in the culture medium and displayed the expected 
apparent molecular weight of 83 kDa (Fig. 1B). Cor-
rect folding was assessed by measuring alkaline 
phosphatase (AP) activity towards 
4-nitrophenyldisodium orthophosphate, pNPP (Fig. 
1C). All conditioned media, except for BR7ecto225, 
met the minimal AP specific activity requirements for 
RAP in situ purposes [30]. In all subsequent experi-
ments specific AP activities were equalized and un-
fused PLAP-containing conditioned medium served 
as control.  
PTPBR7 extracellular domain binds to mye-
linated tracts in mouse brain 
The different PTPBR7 ectodomain-AP fusion 
probes, except for BR7ecto225, were used on sagittal 
sections of adult mouse brain. Positive staining was 
observed in regions of the corpus callosum, alveus, 
fimbria fornix, anterior commisure of olfactory bulb, 
hippocampal area in the cerebrum and in cerebel-
lar-related fiber tracts (Fig. 2), all regions associated 
with high myelination [33]. These RAP in situ-positive 
regions of the cerebrum only partially coincide with 
the areas where the Ptprr gene is expressed as deter-
mined by RNA in situ hybridization [18]. No qualita-
tive differences in the binding patterns were observed 
for the various ectodomain probes, indicating com-
parable binding abilities (data not shown). The pat-
terns are distinct from those obtained using RPTPσ 
extracellular probes [11, 31], underscoring specificity. 
PTPBR7 extracellular domain binds to white 
matter in mouse cerebellum 
Past studies showed that gene Ptprr displays 
highest expression levels in granular layer and PCs in 
the adult mouse cerebellum [18]. RAP in situ staining 
using the various PTPBR7 ectodomain probes result-
ed in positive signals for white matter of the cerebel-
lum. Some staining was also present in PCs, single 
neurons of the granular layer and tracts of the molec-
ular layer (Fig. 3). The pattern observed in the white 
matter is reminiscent of that of myelinating oli-
godendrocytes, as revealed by 2’-3’-cyclic-nucleotide 
3’-phosphodiesterase (CNPase) immunoreactivity 
(Fig. 3D).  
We next examined whether PTPRR deficiency 
may have an impact on the localization and level of 
expression of putative PTPBR7 ligands. No apparent 
difference in the BR7ecto226 binding patterns was 
observed when comparing wild type and Ptprr 
knock-out cerebellar sections (data not shown). 
An attempt to reduce the staining intensity of the 
BR7ecto226 probe by adding increasing amounts of a 
6-Histidine tagged version of this PTPBR7 extracellu-
lar segment (BR7ecto226-His) was not successful 
(Supplementary Material: Fig. S2), leading us to con-
clude that either saturation of binding sites could not 
be achieved under these conditions or that 
AP-mediated dimerization [30] of the BR7ecto226 
probe is favouring ligand binding over that of the 
monomeric His-tagged competitor. It has been shown 
that monomeric RPTPσ binds less well to ligands un-
der RAP conditions as compared to the dimeric probe 
[34]. 
Assessment of binding to heparan sulphate and 
chondroitin sulphate GAGs  
Sulphated glycosaminoglycans (GAGs) have 
important roles in development and plasticity in the 
postnatal brain [35] and some have turned out to be 
RPTP ligands [6]. We therefore tested whether the 
PTPBR7 ectodomain could directly bind to a panel of 
GAG modifications using a tailored ELISA protocol 
[25]. Successful coating of purified HS and CS-A, -C, 
-D and -E chains onto microtiter plate wells was con-
firmed by the application of single chain GAG-specific 
antibodies in parallel control wells (data not shown). 
Direct binding of probe BR7ecto226 to the HS and CS 
molecules, as determined by measuring AP activity in 
the wells, could not be demonstrated in this set-up 
(Fig. 4). This may also reflect an essential contribution 
of the GAGs protein moiety to the binding and, 
therefore, we performed a complementary experi-
ment using the RAP in situ assay. Removal of the 
most abundant GAG modification in the CNS, CS, by 
chondroitinase ABC treatment did not alter the 
staining pattern or the staining intensity of the 
BR7ecto226 probe on cerebellar tissue sections (Fig. 5). 
Successful chondroitinase ABC treatment could be 
confirmed independently using the aforementioned 
ELISA assay (data not shown). Finally, RAP in situ 
staining patterns showed GAG-mediated basal lami-
na binding for RPTPσ [11] but not for PTPRR probes 
(Figure 4). These findings imply that HS and CS are 
not the major binding sites for the PTPBR7 extracel-
lular domain.  
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Fig. 1. Characterization of PTPBR7 ectodomain fusion proteins used for RAP in situ assays on mouse brain sections. (A) 
Schematic representation of mouse PTPBR7 (72 kDa) and the various BR7ecto probes (83 kDa). Signal peptide (SP), hy-
drophobic (HR) and transmembrane (TM) regions, kinase-interacting motif (KIM), catalytic protein tyrosine phosphatase 
domain (PTP), flexible Glycine linker (Gly linker), Placental alkaline phosphatase enzyme (PLAP) and the segment recognised 
by the -BR7 antiserum are indicated. The seven amino acid residues (position 220, 221, 222, 223, 224, 225 and 226 in 
PTPBR7) that form the seven different junctions between the extracellular domain and the Glycine linker are highlighted in 
bold. Resulting probes are named ‘BR7ecto’ followed by the fusion residue number. (B) Expression and secretion of BR7ecto 
probes as detected on immunoblots. Conditioned culture media of HEK293T cells transiently transfected with 
pBG-flexilinker-based expression constructs for the various BR7ecto probes (indicated by the respective fusion residue 
number on the top of each lane) were subjected to SDS-PAGE and immunoblotted using rabbit polyclonal -BR7 antiserum. 
The arrowhead points at the position of the BR7ecto probes. Molecular size markers (in kDa) are indicated on the left. (C) 
Graph reporting the alkaline phosphatase activity within the different BR7ecto probe-containing conditioned media as 
determined spectrophotometrically using pNPP as a substrate. 
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Fig. 2. The PTPBR7 ectodomain binds specifically to highly myelinated regions in mouse brain. RAP in situ assays using 
BR7ecto226 (A), BR7ecto224 (B) and control PLAP protein (C) as a probe were performed on adult mouse brain cryo-
sections. Reddish-purple staining was identified in corpus callosum (cc), alveus (alv), fimbria (fi), columns of the fornix (fx), 
anterior commissure of olfactory bulb (aco), hippocampal fissure (hf) in the cerebrum and cerebellar-related fiber tracts 
(wm). Probes BR7ecto220, BR7ecto221, BR7ecto222 and BR7ecto223 gave identical results. Bar = 1 mm. 
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Fig. 3. Binding pattern of the BR7ecto226 
probe in adult mouse cerebellum. Low (A) 
and high (B) magnification of the cerebel-
lum show strong staining concentrated in 
white matter (wm). Less intense staining is 
observed in Purkinje cells (pl, arrows), in 
single cells of the granular layer (gl) and in 
tracts (arrowhead) of the molecular layer 
(ml). (C) Enlargement of the region in 
panel A (dashed rectangle) showing de-
tailed staining of fiber tracts at the white 
matter branching. D) Using monoclonal 
antibody 11-5B immuno-reactivity for 
CNPase was detected in white matter 
(wm), resembling the BR7ecto226 staining 
pattern (C), with fiber tracts elongating 
from the white matter into the granular 
layer (gl). Bars represent 1 mm (A) and 0.1 
mm (C,D). 
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Fig. 4. PTPBR7 ectodomain does not bind to heparan sulphate and chondroitin sulphate moieties. (A) Medium containing 
the BR7ecto226 probe was added to microplate wells previously coated with one of the indicated GAG chains, or with 
coating buffer as a control. Binding was assessed by addition of pNPP as substrate and measuring absorption (ABS) at 405 
nm. Successful coating of the wells was confirmed separately, exploiting GAG-specific antibodies. Intensities did not sig-
nificantly differ in comparison with the uncoated control. Results (n=3) are presented as Mean ± S.D. (B) RAP in situ staining 
of the epidermis (arrow) in mouse embryonic cryosections using BR7ecto226 as a probe. (C) The RPTPσ  ectodomain 
probe displays distinct binding to the basal laminae (arrow), whereas BR7ecto226 does not. 
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Fig. 5. Removal of CS chains does not alter PTPBR7 ectodomain binding to cerebellar white matter. BR7ecto226 
probe-containing medium was incubated on Chondroitinase ABC-treated coronal sections of mouse cerebellum (B), and on 
non-treated control sections (A), according to the RAP in situ procedure. Low magnification images do not show overt 
differences in binding. Chondroitinase ABC activity was confirmed separately, exploiting GAG-specific antibodies (data not 
shown). Sections stained with unfused PLAP-containing medium (C) served as control. (D) Quantification of staining in-
tensities within the white matter. Mean gray values are shown. The experiment was done in triplicate and BR7ecto226 and 
PLAP staining intensities were consistently found to be significantly different. Results (n=3) are presented as Mean ± S.D. 
(p=0.0013). CHON= chondroitinase ABC. No treat = no treatment. Bar = 1 mm. 
 
 
Candidate proteins that bind to the PTPBR7 
extracellular domain 
As an approach to directly identify candidate 
protein molecules that can bind to the PTPBR7 extra-
cellular segment, we exploited the BR7ecto226-His 
fusion protein to affinity-purify such proteins from 
mouse brain lysates. Two independent purifications 
were undertaken to address reproducibility. Fur-
thermore, a similar procedure was followed using the 
His-tagged RPTPμ extracellular domain [24] as affin-
ity reagent, to verify specificity of the procedure. 
His-tagged ectodomains were produced in transfect-
ed HEK293T cells, purified using nickel beads and 
subsequently used to capture mouse brain proteins. 
The ectodomain-displaying beads were extensively 
washed and the specifically bound proteins were then 
eluted and size-separated on SDS-PAGE. Relevant gel 
lanes were then excised and subjected to enzymatic 
digestion. Retrieved peptides were subsequently 
identified by means of nanoLC coupled to mass spec-
trometry.  
 Peptides of three different proteins were re-
trieved reproducibly in the duplicate 
BR7ecto226-purified samples (Table 1): the guanine 
nucleotide-binding protein G(o) subunit alpha 
(Gnao1), the IgLON family cell adhesion molecule 
Neurotrimin (Ntm), and α/β subunits of Calci-
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um/calmodulin-dependent kinase II (Camk2a/b). 
These peptides did not overlap with those affini-
ty-purified using RPTPμ extracellular domain or 
nickel beads alone as controls and generated protein 
Mascot scores above 60, minimizing false positive 
rates. It is of note that PSD-95, the most abundant 
membrane-associated protein of the post-synaptic 
density fraction, was not present in our isolates. Both 
findings support the specificity of the applied proce-
dure. At first sight it may come as a surprise to find 
cytoplasmic candidates like Gαo and CaMKII when 
using extracellular protein segments as bait but under 
the conditions used there might still be multi-subunit 
protein complexes that could explain co-purification. 
Future experiments should aim at the validation and 
functional testing of the identified binding proteins. 
 
Table 1. Proteins identified by LC/MS-MS and Mascot Search that were affinity-purified from brain lysates using 
BR7ecto226-His as bait. Proteins that had Mascot scores above 60 and did not purify in isolates using an unrelated 
His-tagged bait or nickel beads alone are listed. Data from two independent isolates are shown. A full list of proteins 
identified in this way is provided as (Supplementary Material: Table S1). *CaMKII protein was detectable in control samples 
but Mascot scores (38) were below threshold. Subunits α and β of CaMKII have high sequence identity and could not be 
distinguished in the analysis. 
Protein name 
 
Protein mne-
monic identifier 
Uniprot Acces-
sion number 
Mass 
(kDa) 
Mascot 
scores 
Queries 
matched 
Function 
Guanine nucleotide-binding 
protein G(o) subunit alpha 
Gnao1 GNAO_MOUSE 40 85 2 Modulator / transducer of GPCR sig-
naling. G(o) protein function is not 
clear. GNAO1 mutation implicated in 
breast cancer 
139 5 
Neurotrimin Ntm NTRI_MOUSE 38 77 5 Neural cell adhesion molecule of the 
IgLON subfamily of immunoglobulins 
31 1 
Calcium/calmodulin- 
dependent protein kinase 
type II 
Camk2a 
Camk2b 
KCC2A_MOUSE 
KCC2B_MOUSE 
54 
60 
153* 4 Prominent kinase in the central nervous 
system, implicated in long-term poten-
tiation and neurotransmitter release 200* 5 
 
 
Discussion 
 The mouse gene Ptprr encodes a receptor-like 
transmembrane protein isoform, PTPBR7, which is 
expressed on many cells of neuronal origin [18]. Our 
previous work has shown that PTPBR7 phosphatase 
activity is negatively regulated through ho-
mo-multimerisation [17]. Combined with the pheno-
type displayed by Ptprr knock-out mice [19] this 
prompted us to search for putative PTPBR7 ligands. 
Exploiting the RAP in situ strategy we localised 
binding sites for the extracellular domain of PTPBR7 
to highly myelinated areas in mouse brain, including 
white matter of the cerebellum. While highly sul-
phated GAGs proved to be ligands for RPTPσ and 
PTP-LAR [7, 9, 11], we found no evidence for an in-
teraction of the PTPBR7 ectodomain with HS and CS 
in vitro or in situ. In parallel, we used the PTPBR7 ex-
tracellular domain to affinity-purify candidate protein 
ligands from brain lysates and used mass spectrome-
try for identification. The obtained associating pro-
teins (Gαo, Neurotrimin and CaMKII) point to 
Ca2+-regulated processes, cell-cell communication and 
adhesion. Immunopurification of endogenous protein 
complexes containing any of these three proteins and 
PTPBR7, exploiting brain lysates from wildtype and 
Ptprr-/- animals, was unsuccessful (our unpublished 
results). This may be due to aspecificity or lack of 
sensitivity of the antibodies used, but could also re-
flect that only a small subset of the proteins is in-
volved in the interaction or that their encounter is 
transient. It is of note that also ERK1/2 MAP kinases, 
well-established PTPBR7 interactors, were not de-
tected in these experiments, and reports on ERK-PTP 
complexes indeed are based on ectopic expression.  
 We found that highly myelinated tracts in adult 
brain tissue represent preferred sites of PTPBR7 ec-
todomain binding. These regions do not mirror Ptprr 
expression patterns as revealed by RNA in situ hy-
bridisation [18], which may reflect PTPBR7 localiza-
tion and interactions on neuronal processes far away 
from the cell body. The concordance of PTPBR7 lig-
and staining with myelinating oligodendrocytes in 
cerebellar white matter may even point to a role for 
PTPBR7 in the process of myelination. A direct role in 
remyelination has been demonstrated for another 
RPTP, RPTPζ/β, whose expression is induced within 
remyelinating oligodendrocytes in multiple sclerosis 
lesions [36]. The locomotive impairment observed in 
Ptprr-/- animals [19], however, is not accompanied by 
obvious myelination defects arguing against such a 
role for PTPBR7. 
Myelination, neurite outgrowth and synaptic 
plasticity are strongly based on cell adhesion mecha-
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nisms [1, 2]. Intriguingly, a cell-cell adhesion molecule 
presented as a candidate interactor of the PTPBR7 
extracellular domain; Neurotrimin (Table 1). Neu-
rotrimin is a member of the IgLON family of neural 
cell adhesion molecules that contains members like 
Neuronal growth regulator 1, LSAMP and 
OBCAM/OPCML. In vitro and in vivo studies indicate 
that IgLON members either enhance or inhibit neurite 
outgrowth and synaptogenesis [37]. Neurotrimin is 
expressed in cerebellar granule and Purkinje cells and 
its developmental pattern of expression points to roles 
in axon fasciculation and synaptogenesis [38]. 
PTPBR7 is expressed at all developmental stages in 
mouse cerebellar granular cells. In contrast, its ex-
pression in Purkinje cells gradually decreases over the 
first weeks after birth [18]. The putative PTPBR7 – 
Neurotrimin interaction may well contribute to 
Purkinje cell maturation and parallel fiber synapto-
genesis, processes that are essential for cerebellar 
functioning in locomotive processes. 
The identification of cytosolic CaMKII α/β 
subunits as a candidate interactor that is reproducibly 
purified using the extracellular domain of PTPBR7 
first came as a surprise. However, we also found 
CaMKII binding to the tyrosine phosphatase domain 
of PTPBR7 in an independent glutathione 
S-transferase pull-down experiment (unpublished 
data). Since PTPBR7 is able to form homo-multimers 
[17] it might be that the PTPBR7 ectodomain stably 
associates with full-length PTPBR7 and its associating 
proteins from mouse brain lysate. This may involve 
cell surface-exposed PTPBR7 but could also address 
PTPBR7-containing complexes following its internal-
isation and subsequent vesicular trafficking. Alterna-
tively, other CaMKII-associated transmembrane pro-
teins may mediate the interaction with the PTPBR7 
ectodomain probe. A similar type of reasoning may 
underlie the identification of Gαo in BR7ecto226-His 
purified material. 
 CaMKII is highly expressed in brain and its 
serine/threonine kinase activity is dependent on in-
creased calcium levels. The enzyme is concentrated in 
the post synaptic density (PSD) fraction and is criti-
cally involved in the synaptic plasticity that underlies 
processes of learning and memory [39]. Mice lacking 
CaMKIIα display limbic epilepsy [40]. Also Gαo 
functioning has been linked to neuronal calcium sig-
nalling processes and locomotion. The study of ionic 
currents in mouse hippocampal CA3 neurons re-
vealed that modulation of Ca2+ currents by G pro-
tein-coupled receptors is changed and much slower 
recovery kinetics are displayed when Gαo isoforms 
are lacking [41]. Gαo deficient animals have normal 
brain morphology but suffer from tremors and occa-
sional seizures, display severe motor control impair-
ment and have a reduced life span of only two months 
[42, 43]. Intriguingly, locomotive impairment com-
bined with normal brain morphology was also ob-
served in Ptprr-/- mice [19] and in several mouse 
models that lack cerebellar calcium binding proteins 
[20]. A functional interaction between PTPBR7 and 
Gαo or CaMKII containing complexes could well ex-
plain such in vivo parallels. 
 In conclusion, our work puts forward highly 
myelinated areas in brain as a source of PTPBR7 lig-
ands. Using the PTPBR7 extracellular domain as bait, 
we identified protein candidates that lend support to 
PTPBR7 involvement in two major processes. On the 
one hand as part of cell-cell adhesion complexes dur-
ing cerebellar development; on the other hand in cal-
cium ion-regulated events that are instrumental in 
neuronal development and plasticity. This provides a 
working hypothesis to start testing the functional im-
plications of the observed interactions in cell and 
animal models. 
Supplementary Material 
Figure S1: Schematic representation of the 
pBG-flexilinker vector used to generate RAP in situ 
probes. Figure S2: The binding of BR7ecto226 probe to 
the mouse cerebellum is not altered by the PTPBR7 
extracellular domain itself. Table S1: Mascot scores for 
proteins identified by LC‐ESI‐FT‐MS/MS that were 
affinity‐purified from brain lysates. 
http://www.biolsci.org/v07p0978s1.pdf 
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